RNAWay
)
RNAWay addresses a critical unmet need in the rapidly growing RNA crop protection market: effective and scalable delivery into plants. Despite significant investment in RNA technologies, delivery has remained the main barrier to commercialization. RNAWay has developed a patented molecular delivery platform enabling stable, systemic RNA uptake via spray or irrigation, with demonstrated field efficacy against major plant pathogens. The platform supports both partnerships with industry leaders and the development of RNAWay’s own products.
Category: Crop Protection / Next-gen Genomics
HQ: Israel (Technion spin-out)
Founded: 2021
Employees: 5
Raised so far: $2.65M
Backed by: BASF, ICA and Copia, and supported by leading academic institutions including the Technion and the Hebrew University of Jerusalem.
Looking to engage with: Strategic partners and investors to support the company’s next growth phase, including pilots, partnerships, and the completion of our current fundraising round.
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
)
)
)
)